Entity Details
| Primary name |
MCLN1_HUMAN |
| Entity type |
UniProt |
| Source |
Source Link |
Details
| Accession | Q9GZU1 |
| EntryName | MCLN1_HUMAN |
| FullName | Mucolipin-1 |
| TaxID | 9606 |
| Evidence | evidence at protein level |
| Length | 580 |
| SequenceStatus | complete |
| DateCreated | 2004-07-19 |
| DateModified | 2021-06-02 |
Subcellular Location
Show/Hide Table
| Subcellular Location |
| Cell membrane |
| Cell projection |
| Cytoplasmic vesicle |
| Cytoplasmic vesicle membrane |
| Late endosome membrane |
| Lysosome membrane |
Domains
Show/Hide Table
| Domain | Name | Category | Type |
| IPR013122 | Polycystin cation channel, PKD1/PKD2 | Domain | Domain |
| IPR039031 | Mucolipin | Family | Family |
Diseases
Show/Hide Table
| Disease ID | Source | Name | Description |
| 252650 | OMIM | Mucolipidosis 4 (ML4) | An autosomal recessive lysosomal storage disorder characterized by severe psychomotor retardation and ophthalmologic abnormalities, including corneal opacity, retinal degeneration and strabismus. Storage bodies of lipids and water-soluble substances are seen by electron microscopy in almost every cell type of the patients. Most patients are unable to speak or walk independently and reach a maximal developmental level of 1-2 years. All patients have constitutive achlorhydia associated with a secondary elevation of serum gastrin levels. The disease is caused by variants affecting the gene represented in this entry. |
Interactions
6 interactions